Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Other glycan degradation	6/18	1.0069122041429385e-14	8.055297633143508e-14	1007.0	-923.6157517299393	AGA;FUCA1;GLB1;MAN2B1;MANBA;NEU1
KEGG_2021_Human	Lysosome	8/128	1.3979667301701514e-13	5.591866920680606e-13	264.93333333333334	-457.4549917212001	AGA;CTSA;FUCA1;GLB1;MAN2B1;MANBA;NAGA;NEU1
KEGG_2021_Human	Glycosphingolipid biosynthesis	2/45	0.0013273471832161057	0.003145129744310649	46.656976744186046	-54.75457721637333	GLB1;NAGA
KEGG_2021_Human	Sphingolipid metabolism	2/49	0.0015725648721553246	0.003145129744310649	42.66489361702128	-51.011826705781694	GLB1;NEU1
KEGG_2021_Human	Glycosaminoglycan degradation	1/19	0.023286116400967973	0.037257786241548754	49.69135802469136	-23.981021494289497	GLB1
KEGG_2021_Human	Renin-angiotensin system	1/23	0.028125816737661832	0.03750108898354911	40.63636363636363	-20.601670877696893	CTSA
KEGG_2021_Human	Galactose metabolism	1/31	0.03774052193970927	0.04313202507395345	29.77037037037037	-16.126223630092912	GLB1
KEGG_2021_Human	Wnt signaling pathway	1/166	0.1875932968535885	0.1875932968535885	5.321885521885521	-2.9652743858654524	SOX17
